You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ruxolitinib

Showing 1 - 25 of 181
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Ruxolitinib
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • Ruxolitinib
  • (no location specified)
Feb 28, 2023

Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

Approved for marketing
  • Graft-versus-host Disease (GVHD)
  • Ruxolitinib
  • (no location specified)
Jan 26, 2023

Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

Not yet recruiting
  • Haemophagocytic Lymphohistiocytosis
  • Ruxolitinib
  • (no location specified)
Feb 28, 2023

Neuromyelitis Optica Spectrum Disorder Relapse Trial in Tianjin (Ruxolitinib)

Withdrawn
  • Neuromyelitis Optica Spectrum Disorder Relapse
  • Ruxolitinib
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Jun 10, 2023

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Ruxolitinib
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Ruxolitinib
  • Pegylated interferon α-2b
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Ruxolitinib in Patients With Myelofibrosis

Completed
  • Myelofibrosis
  • Ruxolitinib
  • (no location specified)
Jun 5, 2022

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)

Not yet recruiting
  • T-Cell Large Granular Lymphocyte Leukemia
  • Ruxolitinib
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 20, 2022

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)

Recruiting
  • Chronic Hand Dermatitis
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
Aug 9, 2022

Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Myelofibrosis Trial in Jinan (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Ruxolitinib
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jul 3, 2022

Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)

Recruiting
  • Hematopoietic Stem Cell Transplant (HSCT)
  • Bronchiolitis Obliterans (BO)
  • Ruxolitinib
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 6, 2022

Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

Recruiting
  • Colorectal Cancer
  • Pancreatic Adenocarcinoma
  • Singapore, Singapore
    National Cancer Centre
Jun 10, 2022

Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)

Recruiting
  • Bronchiolitis Obliterans Syndrome
  • Hematologic Malignancy
  • Ruxolitinib
  • Hangzhou, Zhejiang, China
    The first Affiliated Hospital of Zhejiang University
Oct 18, 2022

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

Not yet recruiting
  • Graft Vs Host Disease
  • +2 more
  • Ruxolitinib
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 18, 2023

Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Ruxolitinib
  • Tucson, Arizona
  • +1 more
Sep 22, 2022

Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)

Enrolling by invitation
  • Discoid Lupus Erythematosus
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
May 20, 2022

Myelofibrosis Trial in United States (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Ruxolitinib
  • Boston, Massachusetts
  • +4 more
Oct 21, 2022

Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Cellular Therapy
  • Ruxolitinib
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)

Completed
  • Necrobiosis Lipoidica
  • Ruxolitinib
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 17, 2022